Ascent Therapeutics Company
Ascent Therapeutics offers Pepducins targeting GPCRs on the cell membrane, expanding the GPCR frontier.
Technology:
Anti-infective Drugs
Industry:
PharmTech
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
2006
Employees Number:
1-10
Funding Status:
Early Stage Venture
Estimated Revenue:
$1M to $10M
Register and Claim Ownership